Cargando…
Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma
BACKGROUND: The involvement of lipid metabolism in tumourigenesis and the progression of clear cell renal cell carcinoma (ccRCC) have been reported. However, the role of phospholipid profile alterations in ccRCC has not yet been systematically explored. In the present study, we compared the phosphol...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427523/ https://www.ncbi.nlm.nih.gov/pubmed/28494778 http://dx.doi.org/10.1186/s13046-017-0525-1 |
_version_ | 1783235643552301056 |
---|---|
author | Du, Yiqing Wang, Qiang Zhang, Xingzhong Wang, Xiaofeng Qin, Caipeng Sheng, Zhengzuo Yin, Huaqi Jiang, Changtao Li, Jing Xu, Tao |
author_facet | Du, Yiqing Wang, Qiang Zhang, Xingzhong Wang, Xiaofeng Qin, Caipeng Sheng, Zhengzuo Yin, Huaqi Jiang, Changtao Li, Jing Xu, Tao |
author_sort | Du, Yiqing |
collection | PubMed |
description | BACKGROUND: The involvement of lipid metabolism in tumourigenesis and the progression of clear cell renal cell carcinoma (ccRCC) have been reported. However, the role of phospholipid profile alterations in ccRCC has not yet been systematically explored. In the present study, we compared the phospholipid compositions between ccRCC and paired normal renal tissues. METHODS: The phospholipid compositions of paired ccRCC and normal renal tissues were evaluated using liquid chromatography tandem mass spectrometry (LC/MS/MS). To evaluate the mRNA and protein levels of lysophosphatidylcholine acyltransferase (LPCAT), which converts lysophosphatidylcholine (LPC) to phosphatidylcholine (PC), qRT-PCR, western blotting and immunohistochemistry were performed. The correlations of LPCAT1 expression with clinicopathological features and prognosis were assessed. In addition, siRNAs were used to knockdown LPCAT1 expression in ccRCC cell lines, and its effect on cell proliferation, cell cycle, migration and invasion were investigated. RESULTS: The phospholipid compositions of ccRCC and normal renal tissues were significantly different. Multiple LPC species were decreased and corresponding PC species were increased in cancer tissues. The mRNA and protein levels of LPCAT1 were up-regulated in ccRCC tissues compared with normal renal tissues, and LPCAT1 expression was significantly correlated with unfavourable pathological features (higher tumour grade, higher TNM stage and larger tumour size) and overall survival. In cell line experiments, LPCAT1 knockdown depleted PCs, inhibited cell proliferation, migration and invasion and induced cell cycle arrest at the G0/G1 phase. CONCLUSION: Selective changes in PC and LPC composition were observed in ccRCC tissues. The overexpression of LPCAT1 promotes the development and progression of ccRCC, likely through the conversion of LPC to PC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-017-0525-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5427523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54275232017-05-12 Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma Du, Yiqing Wang, Qiang Zhang, Xingzhong Wang, Xiaofeng Qin, Caipeng Sheng, Zhengzuo Yin, Huaqi Jiang, Changtao Li, Jing Xu, Tao J Exp Clin Cancer Res Research BACKGROUND: The involvement of lipid metabolism in tumourigenesis and the progression of clear cell renal cell carcinoma (ccRCC) have been reported. However, the role of phospholipid profile alterations in ccRCC has not yet been systematically explored. In the present study, we compared the phospholipid compositions between ccRCC and paired normal renal tissues. METHODS: The phospholipid compositions of paired ccRCC and normal renal tissues were evaluated using liquid chromatography tandem mass spectrometry (LC/MS/MS). To evaluate the mRNA and protein levels of lysophosphatidylcholine acyltransferase (LPCAT), which converts lysophosphatidylcholine (LPC) to phosphatidylcholine (PC), qRT-PCR, western blotting and immunohistochemistry were performed. The correlations of LPCAT1 expression with clinicopathological features and prognosis were assessed. In addition, siRNAs were used to knockdown LPCAT1 expression in ccRCC cell lines, and its effect on cell proliferation, cell cycle, migration and invasion were investigated. RESULTS: The phospholipid compositions of ccRCC and normal renal tissues were significantly different. Multiple LPC species were decreased and corresponding PC species were increased in cancer tissues. The mRNA and protein levels of LPCAT1 were up-regulated in ccRCC tissues compared with normal renal tissues, and LPCAT1 expression was significantly correlated with unfavourable pathological features (higher tumour grade, higher TNM stage and larger tumour size) and overall survival. In cell line experiments, LPCAT1 knockdown depleted PCs, inhibited cell proliferation, migration and invasion and induced cell cycle arrest at the G0/G1 phase. CONCLUSION: Selective changes in PC and LPC composition were observed in ccRCC tissues. The overexpression of LPCAT1 promotes the development and progression of ccRCC, likely through the conversion of LPC to PC. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13046-017-0525-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-12 /pmc/articles/PMC5427523/ /pubmed/28494778 http://dx.doi.org/10.1186/s13046-017-0525-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Du, Yiqing Wang, Qiang Zhang, Xingzhong Wang, Xiaofeng Qin, Caipeng Sheng, Zhengzuo Yin, Huaqi Jiang, Changtao Li, Jing Xu, Tao Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma |
title | Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma |
title_full | Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma |
title_fullStr | Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma |
title_full_unstemmed | Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma |
title_short | Lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma |
title_sort | lysophosphatidylcholine acyltransferase 1 upregulation and concomitant phospholipid alterations in clear cell renal cell carcinoma |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427523/ https://www.ncbi.nlm.nih.gov/pubmed/28494778 http://dx.doi.org/10.1186/s13046-017-0525-1 |
work_keys_str_mv | AT duyiqing lysophosphatidylcholineacyltransferase1upregulationandconcomitantphospholipidalterationsinclearcellrenalcellcarcinoma AT wangqiang lysophosphatidylcholineacyltransferase1upregulationandconcomitantphospholipidalterationsinclearcellrenalcellcarcinoma AT zhangxingzhong lysophosphatidylcholineacyltransferase1upregulationandconcomitantphospholipidalterationsinclearcellrenalcellcarcinoma AT wangxiaofeng lysophosphatidylcholineacyltransferase1upregulationandconcomitantphospholipidalterationsinclearcellrenalcellcarcinoma AT qincaipeng lysophosphatidylcholineacyltransferase1upregulationandconcomitantphospholipidalterationsinclearcellrenalcellcarcinoma AT shengzhengzuo lysophosphatidylcholineacyltransferase1upregulationandconcomitantphospholipidalterationsinclearcellrenalcellcarcinoma AT yinhuaqi lysophosphatidylcholineacyltransferase1upregulationandconcomitantphospholipidalterationsinclearcellrenalcellcarcinoma AT jiangchangtao lysophosphatidylcholineacyltransferase1upregulationandconcomitantphospholipidalterationsinclearcellrenalcellcarcinoma AT lijing lysophosphatidylcholineacyltransferase1upregulationandconcomitantphospholipidalterationsinclearcellrenalcellcarcinoma AT xutao lysophosphatidylcholineacyltransferase1upregulationandconcomitantphospholipidalterationsinclearcellrenalcellcarcinoma |